Confluent CEO files Form 4; 232,500 Class A shares sold at ~$18.66
Rhea-AI Filing Summary
Edward J. Kreps, who is identified as both Chief Executive Officer and a director of Confluent, Inc. (CFLT), reported same-day non-derivative transactions in the issuer's common stock on 09/04/2025. The Form 4 shows 232,500 shares of Class A common stock were acquired (transaction code C) and an equal number, 232,500 shares were sold (transaction code S) at prices reported in a range from $18.35 to $18.955 and an aggregate per-share reference of $18.66 on the form. Following the reported transactions, the filing lists 377,074 shares of Class A common stock beneficially owned directly by the reporting person. The filing also discloses multiple indirect holdings of Class A common stock held in family trusts totaling disclosed blocks of 149,984 and two 1,000,000-share holdings, and a large block of Class A shares shown as underlying Class B conversion.
Positive
- Transactions were reported promptly on a Form 4, improving transparency for shareholders.
- Sale conducted under a 10b5-1 trading plan, which provides an affirmative defense under Rule 10b5-1.
Negative
- Direct beneficial ownership decreased by 232,500 Class A shares as a result of the reported sale.
- Substantial indirect holdings remain in family trusts, which can concentrate voting power and economic exposure.
Insights
TL;DR: Routine insider transactions under a 10b5-1 plan, combining conversion and immediate sale, produce modest change to direct holdings.
The Form 4 documents same-day activity where the reporting person converted or otherwise acquired 232,500 Class A shares and sold 232,500 shares the same day under a previously adopted 10b5-1 plan. The sale prices are disclosed as a range ($18.35–$18.955) with a reference per-share figure of $18.66 on the form. These transactions reduced the reporting person's reported direct beneficial ownership to 377,074 Class A shares while leaving significant indirect holdings in family trusts. For investors, this appears procedural and consistent with plan-based liquidity rather than an operational signal about Confluent's fundamentals.
TL;DR: Compliance and transparency are evident: transactions were reported and tied to a 10b5-1 plan; large indirect holdings remain in trusts.
The Form 4 properly flags the sale as pursuant to a 10b5-1 trading plan adopted August 15, 2024, which supports the affirmative defense to insider trading claims. The filing discloses both direct and indirect holdings, including conversion mechanics between Class B and Class A shares, and identifies trusts that hold material blocks of common stock. From a governance perspective, timely reporting and clear footnotes on conversion and trust ownership improve transparency for shareholders monitoring insider activity.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Class B Common Stock | 232,500 | $0.00 | -- |
| Conversion | Class A Common Stock | 232,500 | $0.00 | -- |
| Sale | Class A Common Stock | 232,500 | $18.66 | $4.34M |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
Footnotes (1)
- Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock. Shares sold pursuant to a 10b5-1 trading plan adopted August 15, 2024. The shares were sold at prices ranging from $18.35 to $18.955. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The shares are held by The Edward J. Kreps and Jamaica H. Kreps 2018 Revocable Trust. The shares are held by the GST Exempt Trust under The Kreps Family 2019 Irrevocable Trust under agreement dated 9/26/2019. The shares are held by the GST Exempt Trust under The Kreps Family 2019 Irrevocable Trust under agreement dated 9/26/2019.
